Articles for Polly Clayden
How we know a new medicine is so effective at preventing HIV transmission
There was not a single HIV transmission in a clinical trial in which women volunteers used the twice-yearly injectable drug lenacapavir
Science | 1 August 2024
New, better HIV drugs can save billions of rand
But South Africa needs to be proactive to take advantage of new medicines
News | 5 May 2016
Ten things you probably don’t know about HIV in 2016
The HIV world is used to things moving fast, in a way that most medicine just doesn’t.
By Francois Venter, Polly Clayden, Anele Yawa and Marcus Low
Explainer | 22 February 2016